ACADIA Pharmaceuticals Inc. (ACAD)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	253.64	319.59	188.66	114.85	147.44	326.03
Short-Term Investments	508.36	436.4	250.21	301.98	373.27	305.93
Cash & Short-Term Investments	762	755.99	438.87	416.82	520.71	631.96
Cash Growth	52.11%	72.26%	5.29%	-19.95%	-17.60%	-9.39%
Accounts Receivable	107.51	98.74	98.27	62.2	64.37	48.25
Other Receivables	12.18	5.96	4.08	0.89	0.98	2.04
Receivables	119.69	104.7	102.35	63.08	65.34	50.28
Inventory	26.12	21.95	35.82	6.64	7.88	9.68
Prepaid Expenses	52.75	55.68	39.09	21.4	23.89	25.69
Total Current Assets	960.55	938.32	616.13	507.94	617.82	717.62
Property, Plant & Equipment	54.54	50.79	56.47	61.59	66.32	56.44
Long-Term Investments	-	-	-	-	3.6	1.3
Other Intangible Assets	114.34	119.78	65.49	-	-	1.11
Other Long-Term Assets	96.13	78.87	10.87	18.28	12.38	6.15
Total Assets	1,226	1,188	748.96	587.81	700.12	782.62
Accounts Payable	20.1	16.19	17.54	12.75	6.88	8.49
Accrued Expenses	298.23	254.44	196.16	103.58	80.89	92.39
Current Portion of Leases	11.69	9.96	9.41	9.31	8.3	5.09
Current Income Taxes Payable	-	12.02	1.56	-	-	-
Other Current Liabilities	-	102.26	29.58	-	-	-
Total Current Liabilities	330.02	394.87	254.25	125.63	96.07	105.97
Long-Term Leases	44.6	42.04	47.8	52.7	56.13	44.46
Other Long-Term Liabilities	28.55	18.06	15.15	9.07	7.03	5.18
Total Liabilities	403.17	454.96	317.2	187.4	159.23	155.61
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	2,981	2,937	2,863	2,771	2,695	2,613
Retained Earnings	-2,159	-2,204	-2,431	-2,370	-2,154	-1,986
Comprehensive Income & Other	0.41	0.29	0.02	-0.98	-0.19	0.04
Shareholders' Equity	822.38	732.79	431.76	400.41	540.89	627.01
Total Liabilities & Equity	1,226	1,188	748.96	587.81	700.12	782.62
Total Debt	56.29	52	57.21	62	64.43	49.55
Net Cash (Debt)	705.7	704	381.66	354.82	456.28	582.41
Net Cash Growth	59.20%	84.46%	7.56%	-22.23%	-21.66%	-15.30%
Net Cash Per Share	4.22	4.23	2.33	2.19	2.84	3.70
Filing Date Shares Outstanding	168.71	166.79	164.77	162.23	161.2	160.05
Total Common Shares Outstanding	168.61	166.71	164.65	162.06	161.01	159.64
Working Capital	630.53	543.45	361.87	382.31	521.76	611.65
Book Value Per Share	4.88	4.40	2.62	2.47	3.36	3.93
Tangible Book Value	708.04	613.01	366.27	400.41	540.89	625.9
Tangible Book Value Per Share	4.20	3.68	2.22	2.47	3.36	3.92
Machinery	-	10.16	10.42	10.42	10.54	9.08
Construction In Progress	-	0.52	-	-	-	-
Leasehold Improvements	-	3.75	3.75	3.7	3.7	4.03

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q